Coronavirus Testing: ICMR Sets Up Fast Track Mechanism To Validate Kits That Don’t Have U.S. FDA, EU Approvals  
A courier holds an ‘urgent blood test’ sample collected from a private home for testing for coronavirus in Munich, Germany. Photographer: Michaela Handrek-Rehle/Bloomberg

Coronavirus Testing: ICMR Sets Up Fast Track Mechanism To Validate Kits That Don’t Have U.S. FDA, EU Approvals  

Bookmark

The Indian Council of Medical Research said it has recommended two Reverse Transcription Polymerase Chain Reaction test kits for use in ICMR-approved government and private laboratories.

These test kits have been found to have 100 percent concordance among true positive and true negative samples.

The ICMR has established a fast-track mechanism for validation of non-U.S. Food and Drug Administration Emergency Use Authorisation/CE IVD approved kits at ICMR NIV Pune.

Also read: India Issues Guidelines For Private Testing, Ropes In National Labs As Coronavirus Cases Increase

ICMR NIV Pune has completed evaluation of 09 non-U.S. FDA EUA/CE IVD kits. Only test kits with 100 percent concordance among true positive and true negative samples have been recommended for commercial use in India, the statement said.

In addition, U.S. FDA EUA/CE IVD approved kits can be used directly after due approval from DCGI and intimation to ICMR.

BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.